<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ssmu</journal-id><journal-title-group><journal-title xml:lang="ru">Бюллетень сибирской медицины</journal-title><trans-title-group xml:lang="en"><trans-title>Bulletin of Siberian Medicine</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1682-0363</issn><issn pub-type="epub">1819-3684</issn><publisher><publisher-name>Siberian State Medical University, the Ministry of Healthcare of the Russian Federation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.20538/1682-0363-2024-2-91-100</article-id><article-id custom-type="elpub" pub-id-type="custom">ssmu-5666</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL PAPERS</subject></subj-group></article-categories><title-group><article-title>Применение индекса коморбидности Чарльсона для оценки прогноза 18-месячной смертности у пациентов с острым инфарктом миокарда</article-title><trans-title-group xml:lang="en"><trans-title>Application of Charlson Comorbidity Index to assess prognosis of 18-month mortality in patients with acute myocardial infarction</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2013-2647</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Хоанг</surname><given-names>Ч. Х.</given-names></name><name name-style="western" xml:lang="en"><surname>Hoang</surname><given-names>T. H.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Хоанг Чыонг Хюй – канд. мед. наук, преподаватель кафедры внутренних болезней; врач-кардиолог, кардиологическое отделение 5 </p><p>72410, г. Хошимин, ул. Дуонг Куанг Трунг, 02;756335, г. Хошимин, ул. Дуонг Куанг Трунг, 04</p></bio><bio xml:lang="en"><p>02, Duong Quang Trung Str., Ho Chi Minh city, 72410;04, Nguyen Luong Bang Str., Ho Chi Minh City, 756335</p></bio><email xlink:type="simple">truonghh@pnt.du.vn</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0002-2135-2606</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Майсков</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Maiskov</surname><given-names>V. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Майсков Виктор Викторович – канд. мед. наук, доцент кафедры внутренних болезней с курсом кардиологии и функциональной диагностики им. В.С. Моисеева; зав. отделением рентгенохирургических методов диагностики и лечения </p><p>117198, г. Москва, ул. Миклухо-Маклая, 8;117292, г. Москва, ул. Вавилова, 61</p></bio><bio xml:lang="en"><p>8, Mikluho-Maklaya Str., Moscow, 117198;61, Vavilova Str., Moscow, 117292</p></bio><email xlink:type="simple">maiskov-angio@yandex.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6818-8845</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мерай</surname><given-names>И. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Merai</surname><given-names>I. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мерай Имад Ахмадович – канд. мед. наук, доцент кафедры внутренних болезней с курсом кардиологии и функциональной диагностики им. В.С. Моисеева; зав. I отделением реанимации и интенсивной терапии кардио логического профиля </p><p>117198, г. Москва, ул. Миклухо-Маклая, 8;117292, г. Москва, ул. Вавилова, 61</p></bio><bio xml:lang="en"><p>8, Mikluho-Maklaya Str., Moscow, 117198;61, Vavilova Str., Moscow, 117292</p></bio><email xlink:type="simple">imadmerai@yahoo.com</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5873-1768</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кобалава</surname><given-names>Ж. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Kobalava</surname><given-names>Zh. D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кобалава Жанна Давидовна – д-р мед. наук, проф., член-корр. РАН, зав. кафедрой внутренних болезней с курсом кардиологии и функциональной диагностики им. В.С. Моисеева, Медицинский институт </p><p>117198, г. Москва, ул. Миклухо-Маклая, 8</p></bio><bio xml:lang="en"><p>8, Mikluho-Maklaya Str., Moscow, 117198</p></bio><email xlink:type="simple">zkobalava@mail.ru</email><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Медицинский университет Фам Нгок Тач;&#13;
Кардиологическая больница Там Дык</institution><country>Вьетнам</country></aff><aff xml:lang="en"><institution>Pham Ngoc Thach University of Medicine;&#13;
Tam Duc Heart Hospital</institution><country>Viet Nam</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Российский университет дружбы народов (РУДН);&#13;
Городская клиническая больница (ГКБ) им. В.В. Виноградова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Peoples’ Friendship University of Russia (RUDN University);&#13;
Vinogradov City Clinical Hospital</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Российский университет дружбы народов (РУДН)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Peoples’ Friendship University of Russia (RUDN University)</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>10</day><month>07</month><year>2024</year></pub-date><volume>23</volume><issue>2</issue><fpage>91</fpage><lpage>100</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Хоанг Ч.Х., Майсков В.В., Мерай И.А., Кобалава Ж.Д., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Хоанг Ч.Х., Майсков В.В., Мерай И.А., Кобалава Ж.Д.</copyright-holder><copyright-holder xml:lang="en">Hoang T.H., Maiskov V.V., Merai I.A., Kobalava Z.D.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://bulletin.ssmu.ru/jour/article/view/5666">https://bulletin.ssmu.ru/jour/article/view/5666</self-uri><abstract><p>Цель. Оценить прогностическую способность индекса коморбидности Чарльсона (ИКЧ) для прогнозирования 18-месячной смертностиу пациентов с острым инфарктом миокарда (ИМ) с применением номограммы, разработанной на основе математического анализа. Материалы и методы. В проспективное одноцентровое наблюдательное исследование были включены 712 последовательных пациентов с острым ИМ, которым выполняли коронарографию в течение 24 ч с момента госпитализации. Первичной конечной точкой исследования была принята смерть от всех причин в течение 18 мес наблюдения. Для выявления независимых прогностических факторов риска наступления смерти применялся логистический регрессионный анализ. На основе результатов многофакторного анализа была разработана номограмма для прогнозирования клинического исхода. Дискриминационная способность ИКЧ и номограммы была оценена с помощью логистической регрессии, в качестве инструмента оценки его диагностической способности применялся метод ROC-анализа (ROC-анализ). Результаты. Среди пациентов доминировали мужчины (61%), медиана возраста составила 65 лет (интерквартильный размах [ИКР] 56–74 года). Медиана ИКЧ составила 4 (ИКР: 3–6) балла. Смертность в течение 18 мес составила 12,1%, с площадью под ROC-кривой для ИКЧ 0,797 (95%-й доверительный интервал [ДИ] 0,746–0,849; p &lt; 0,001). Многофакторный анализ показал, что ИКЧ (отношение шансов [ОШ] 1,28; 95%-й ДИ 1,08–1,52; p = 0,004), возраст (ОШ 1,06; 95%-й ДИ 1,02–1,09; p = 0,002), трехсосудистое поражение коронарных артерий (ОШ 2,60; 95%-й ДИ 1,36–4,98; p = 0,004), включенные в номограмму, были независимыми предиктивными факторами неблагоприятного клинического исхода. Номограмма продемонстрировала хорошую дискриминационную способность прогнозирования 18-месячной смертности у пациентов с острым ИМ (площадь под ROC-кривой 0,819; 95%-й ДИ 0,767–0,870; p &lt; 0,001; чувствительность 65,1%; специфичность 88,2%). Заключение. ИКЧ независимо ассоциировался и умеренно предсказывал смертность в течение 18 мес у пациентов с острым ИМ. Предложенная номограмма облегчила раннюю идентификацию пациентов с высоким риском событий, что позволило внедрить более эффективные стратегии лечения и снизить смертность при остром ИМ.</p></abstract><trans-abstract xml:lang="en"><p>Aim. To evaluate the prognostic value of the Charlson Comorbidity Index (CCI) for predicting 18-month all-cause mortality and develop a nomogram for predicting 18-month mortality in acute myocardial infarction (MI) patients. Materials and methods. The prospective, single-center, observational study included 712 consecutive patients with acute MI undergoing coronary angiography within 24 hours after hospitalization. The primary endpoint was 18-month all-cause mortality. The logistic regression analysis was adopted to identify independent prognostic factors. A nomogram for predicting the endpoint was developed using the multivariate analysis. The discriminative ability of the CCI and a nomogram were evaluated using the receiver-operating characteristic (ROC) curve analysis. Results. Of the patients, 61% were male, median age was 65 years (interquartile range (IQR) was 56–74 years). Median CCI was 4 (IQR: 3–6) points. The mortality rate was 12.1% at 18 months with the area under the curve (AUC) of 0.797 for CCI (95% confidence interval (CI) 0.746–0.849; p &lt; 0.001). The multivariate analysis revealed that CCI (odds ratio (OR) 1.28; 95% CI 1.08–1.52; p = 0.004), age (OR 1.06; 95% CI 1.02–1.09; p = 0.002), and three-vessel coronary artery disease (OR 2.60; 95% CI 1.36–4.98; p = 0.004), incorporated into the nomogram, were independent predictive factors of an adverse outcome. The nomogram showed good discrimination in predicting 18-month mortality in patients with acute MI (AUC = 0.819; 95% CI 0.767–0.870; p &lt; 0.001; sensitivity 65.1%; specificity 88.2%). Conclusion. CCI was independently associated with and moderately predicted 18-month mortality in patients with acute MI. The proposed nomogram facilitated early identification of high-risk patients, allowing for the implementation of more effective treatment strategies and reducing acute MI mortality</p></trans-abstract><kwd-group xml:lang="ru"><kwd>индекс коморбидности Чарльсона</kwd><kwd>инфаркт миокарда</kwd><kwd>коморбидность</kwd><kwd>смертность</kwd><kwd>номограмма</kwd></kwd-group><kwd-group xml:lang="en"><kwd>Charlson Comorbidity Index</kwd><kwd>comorbidity</kwd><kwd>mortality</kwd><kwd>myocardial infarction</kwd><kwd>nomogram</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Vaduganathan M., Mensah G.A., Turco J.V., Fuster V., Roth G.A. The Global burden of cardiovascular diseases and risk: a compass for future health. J. Am. Coll. Cardiol. 2022;80(25):2361–2371. DOI: 10.1016/j.jacc.2022.11.005.</mixed-citation><mixed-citation xml:lang="en">Vaduganathan M., Mensah G.A., Turco J.V., Fuster V., Roth G.A. The Global burden of cardiovascular diseases and risk: a compass for future health. J. Am. Coll. Cardiol. 2022;80(25):2361–2371. DOI: 10.1016/j.jacc.2022.11.005.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Timmis A., Vardas P., Townsend N., Torbica A., Katus H., De Smedt D. et al. European Society of Cardiology: cardiovascular disease statistics 2021. Eur. Heart J. 2022;43(8):716–799. DOI: 10.1093/ehjqcco/qcac014.</mixed-citation><mixed-citation xml:lang="en">Timmis A., Vardas P., Townsend N., Torbica A., Katus H., De Smedt D. et al. European Society of Cardiology: cardiovascular disease statistics 2021. Eur. Heart J. 2022;43(8):716–799. DOI: 10.1093/ehjqcco/qcac014.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Schmidt M., Jacobsen J.B., Lash T.L., Bøtker H.E., Sørensen H.T. 25 Year trends in first time hospitalisation for acute myocardial infarction, subsequent short and long term mortality, and the prognostic impact of sex and comorbidity: A Danish nationwide cohort study. BMJ. 2012;344:e356. DOI: 10.1136/bmj.e356.</mixed-citation><mixed-citation xml:lang="en">Schmidt M., Jacobsen J.B., Lash T.L., Bøtker H.E., Sørensen H.T. 25 Year trends in first time hospitalisation for acute myocardial infarction, subsequent short and long term mortality, and the prognostic impact of sex and comorbidity: A Danish nationwide cohort study. BMJ. 2012;344:e356. DOI: 10.1136/bmj.e356.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Canivell S., Muller O., Gencer B., Heg D., Klingenberg R., Räber L. et al. Prognosis of cardiovascular and non-cardiovascular multimorbidity after acute coronary syndrome. PLoS One. 2018;13(4):1–12. DOI: 10.1371/journal.pone.0195174.</mixed-citation><mixed-citation xml:lang="en">Canivell S., Muller O., Gencer B., Heg D., Klingenberg R., Räber L. et al. Prognosis of cardiovascular and non-cardiovascular multimorbidity after acute coronary syndrome. PLoS One. 2018;13(4):1–12. DOI: 10.1371/journal.pone.0195174.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang F., Wong C., Chiu Y., Ensor J., Mohamed M.O., Peat G. et al. Prognostic impact of comorbidity measures on outcomes following acute coronary syndrome: A systematic review. Int. J . Clin. Pract. 2021;75(10):1–15. DOI: 10.1111/ijcp.14345.</mixed-citation><mixed-citation xml:lang="en">Zhang F., Wong C., Chiu Y., Ensor J., Mohamed M.O., Peat G. et al. Prognostic impact of comorbidity measures on outcomes following acute coronary syndrome: A systematic review. Int. J . Clin. Pract. 2021;75(10):1–15. DOI: 10.1111/ijcp.14345.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Radovanovic D., Seifert B., Urban P., Eberli F.R., Rickli H., Bertel O. et al. Insights from the nationwide AMIS Plus registry 2002–2012. Heart. 2014;100(4):288–294. DOI: 10.1136/heartjnl-2013-304588</mixed-citation><mixed-citation xml:lang="en">Radovanovic D., Seifert B., Urban P., Eberli F.R., Rickli H., Bertel O. et al. Insights from the nationwide AMIS Plus registry 2002–2012. Heart. 2014;100(4):288–294. DOI: 10.1136/heartjnl-2013-304588</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Thygesen K., Alpert J.S., Jaffe A.S., Simoons M.L., Chaitman B.R., White H.D. et al. Third universal definition of myocardial infarction. Circulation. 2012;126(16):2020–2035. DOI: 10.1161/CIR.0b013e31826e1058.</mixed-citation><mixed-citation xml:lang="en">Thygesen K., Alpert J.S., Jaffe A.S., Simoons M.L., Chaitman B.R., White H.D. et al. Third universal definition of myocardial infarction. Circulation. 2012;126(16):2020–2035. DOI: 10.1161/CIR.0b013e31826e1058.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">MDCalc. Charlson Comorbidity Index (CCI). URL: https://www.mdcalc.com/calc/3917/charlson-comorbidity-index-cci#creator-insights</mixed-citation><mixed-citation xml:lang="en">MDCalc. Charlson Comorbidity Index (CCI). URL: https://www.mdcalc.com/calc/3917/charlson-comorbidity-index-cci#creator-insights</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chronic. Dis. 1987;5(40):373–383. DOI: 10.1016/0021-9681(87)90171-8.</mixed-citation><mixed-citation xml:lang="en">Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chronic. Dis. 1987;5(40):373–383. DOI: 10.1016/0021-9681(87)90171-8.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Fox K.A., Fitzgerald G., Puymirat E., Huang W., Carruthers K., Simon T. et al. Should patients with acute coronary disease be stratified for management according to their risk? Derivation, external validation and outcomes using the updated GRACE risk score. BMJ Open. 2014;4:e004425. DOI: 10.1136/bmjopen-2013-004425.</mixed-citation><mixed-citation xml:lang="en">Fox K.A., Fitzgerald G., Puymirat E., Huang W., Carruthers K., Simon T. et al. Should patients with acute coronary disease be stratified for management according to their risk? Derivation, external validation and outcomes using the updated GRACE risk score. BMJ Open. 2014;4:e004425. DOI: 10.1136/bmjopen-2013-004425.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Nutritional anaemias. Report of a WHO scientific group. World Health Organ. Tech. Rep. Ser. 1968;405:5–37.</mixed-citation><mixed-citation xml:lang="en">Nutritional anaemias. Report of a WHO scientific group. World Health Organ. Tech. Rep. Ser. 1968;405:5–37.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Cui K., Lyu S., Song X., Liu H., Yuan F., Xu F. et al. Longterm safety and efficacy of staged percutaneous coronary intervention for patients with ST-segment elevation myocardial infarction and multivessel coronary disease. Am. J. Cardiol. 2019;124(3):334–342. DOI: 10.1016/j.amjcard.2019.04.048.</mixed-citation><mixed-citation xml:lang="en">Cui K., Lyu S., Song X., Liu H., Yuan F., Xu F. et al. Longterm safety and efficacy of staged percutaneous coronary intervention for patients with ST-segment elevation myocardial infarction and multivessel coronary disease. Am. J. Cardiol. 2019;124(3):334–342. DOI: 10.1016/j.amjcard.2019.04.048.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">DeLong E.R., DeLong D.M., Clarke-Pearson D.L. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44(3):837–845.</mixed-citation><mixed-citation xml:lang="en">DeLong E.R., DeLong D.M., Clarke-Pearson D.L. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44(3):837–845.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang F., Bharadwaj A., Mohamed M.O., Ensor J., Peat G., Mamas M.A. Impact of Charlson Co-Morbidity Index Score on management and outcomes after acute coronary syndrome. Am. J. Cardiol. 2020;130:15–23. DOI: 10.1016/j.amjcard.2020.06.022.</mixed-citation><mixed-citation xml:lang="en">Zhang F., Bharadwaj A., Mohamed M.O., Ensor J., Peat G., Mamas M.A. Impact of Charlson Co-Morbidity Index Score on management and outcomes after acute coronary syndrome. Am. J. Cardiol. 2020;130:15–23. DOI: 10.1016/j.amjcard.2020.06.022.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Hautamäki M., Lyytikäinen L.P., Mahdiani S., Eskola M., Lehtimäki T., Nikus K et al. The association between charlson comorbidity index and mortality in acute coronary syndrome – the MADDEC study coronary syndrome – the MADDEC study. Scand. Cardiovasc. J. 2020;12:1299–1311. DOI: 10.1080/14017431.2019.1693615.</mixed-citation><mixed-citation xml:lang="en">Hautamäki M., Lyytikäinen L.P., Mahdiani S., Eskola M., Lehtimäki T., Nikus K et al. The association between charlson comorbidity index and mortality in acute coronary syndrome – the MADDEC study coronary syndrome – the MADDEC study. Scand. Cardiovasc. J. 2020;12:1299–1311. DOI: 10.1080/14017431.2019.1693615.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Sanchis J., Núñez J., Bodí V., Núñez E., García-Alvarez A., Bonanad C. et al. Influence of comorbid conditions on oneyear outcomes in non – ST-segment elevation acute coronary syndrome. Mayo Clin. Proc. 2011;86(4):291–296. DOI: 10.4065/mcp.2010.0702.</mixed-citation><mixed-citation xml:lang="en">Sanchis J., Núñez J., Bodí V., Núñez E., García-Alvarez A., Bonanad C. et al. Influence of comorbid conditions on oneyear outcomes in non – ST-segment elevation acute coronary syndrome. Mayo Clin. Proc. 2011;86(4):291–296. DOI: 10.4065/mcp.2010.0702.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Núñez J.E., Núñez E., Fácila L., Bertomeu V., Llàcer A., Bodí V. et al. Prognostic Value of Charlson Comorbidity Index at 30 days and 1 year after acute myocardial infarction. Rev. Española Cardiol. 2004;57(9):842–849. DOI: 10.1016/S1885-5857(06)60649-X.</mixed-citation><mixed-citation xml:lang="en">Núñez J.E., Núñez E., Fácila L., Bertomeu V., Llàcer A., Bodí V. et al. Prognostic Value of Charlson Comorbidity Index at 30 days and 1 year after acute myocardial infarction. Rev. Española Cardiol. 2004;57(9):842–849. DOI: 10.1016/S1885-5857(06)60649-X.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">O’Connell R.L., Lim L.L. Utility of the Charlson comorbidity index computed from routinely collected hospital discharge diagnosis codes. Methods Inf. Med. 2000;39(1):7–11.</mixed-citation><mixed-citation xml:lang="en">O’Connell R.L., Lim L.L. Utility of the Charlson comorbidity index computed from routinely collected hospital discharge diagnosis codes. Methods Inf. Med. 2000;39(1):7–11.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Schelde A.B., Schmidt M., Madsen M., Nielsen S.S., Frøkiær J., Christiansen C.F. Impact of the charlson comorbidity index score on risk prediction by single-photon emission computed tomography myocardial perfusion imaging following myocardial infarction. Clin. Epidemiol. 2019;11:901–910. DOI: 10.2147/CLEP.S211555.</mixed-citation><mixed-citation xml:lang="en">Schelde A.B., Schmidt M., Madsen M., Nielsen S.S., Frøkiær J., Christiansen C.F. Impact of the charlson comorbidity index score on risk prediction by single-photon emission computed tomography myocardial perfusion imaging following myocardial infarction. Clin. Epidemiol. 2019;11:901–910. DOI: 10.2147/CLEP.S211555.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Balun A., Akgümüş A. Charlson comorbidity index and 1-year poor outcomes in elderly patients undergoing successful percutaneous coronary intervention: A retrospective study. Med. (United States). 2023;102(19):E33792. DOI: 10.1097/MD.0000000000033792.</mixed-citation><mixed-citation xml:lang="en">Balun A., Akgümüş A. Charlson comorbidity index and 1-year poor outcomes in elderly patients undergoing successful percutaneous coronary intervention: A retrospective study. Med. (United States). 2023;102(19):E33792. DOI: 10.1097/MD.0000000000033792.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Esteve Pastor M.A., Martin E., Alegre O., Castillo Dominguez J.C., Formiga F., Martinez-Selles M. et al. Relationship of Charlson Comorbidity Index with adverse events in elderly patients with acute coronary syndromes: an analysis from LONGEVO-SCA Registry. Eur. Heart J. 2019;40(1):2525. DOI: 10.1093/eurheartj/ehz748.0854.</mixed-citation><mixed-citation xml:lang="en">Esteve Pastor M.A., Martin E., Alegre O., Castillo Dominguez J.C., Formiga F., Martinez-Selles M. et al. Relationship of Charlson Comorbidity Index with adverse events in elderly patients with acute coronary syndromes: an analysis from LONGEVO-SCA Registry. Eur. Heart J. 2019;40(1):2525. DOI: 10.1093/eurheartj/ehz748.0854.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Sanchis J., Soler M., Núñez J., Ruiz V., Bonanad C., Formiga F. et al. Comorbidity assessment for mortality risk stratification in elderly patients with acute coronary syndrome. Eur. J. Intern. Med. 2019;62:48–53. DOI: 10.1016/j.ejim.2019.01.018.</mixed-citation><mixed-citation xml:lang="en">Sanchis J., Soler M., Núñez J., Ruiz V., Bonanad C., Formiga F. et al. Comorbidity assessment for mortality risk stratification in elderly patients with acute coronary syndrome. Eur. J. Intern. Med. 2019;62:48–53. DOI: 10.1016/j.ejim.2019.01.018.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Jiménez-Méndez C., Díez-Villanueva P., Alfonso F. Non-ST segment elevation myocardial infarction in the elderly. Rev. Cardiovasc. Med. 2021;22(3):779–786. DOI: 10.31083/J.RCM2203084.</mixed-citation><mixed-citation xml:lang="en">Jiménez-Méndez C., Díez-Villanueva P., Alfonso F. Non-ST segment elevation myocardial infarction in the elderly. Rev. Cardiovasc. Med. 2021;22(3):779–786. DOI: 10.31083/J.RCM2203084.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Ramirez-Marrero M., Jimenez-Navarro M., De Teresa-Galvan E., De Mora-Martin M. The importance of the Charlson index in risk stratification in patients admitted for acute coronary syndrome without ST-segment elevation. Cardiovasc. Prev. Rehabil. 2011;18(1):S113.</mixed-citation><mixed-citation xml:lang="en">Ramirez-Marrero M., Jimenez-Navarro M., De Teresa-Galvan E., De Mora-Martin M. The importance of the Charlson index in risk stratification in patients admitted for acute coronary syndrome without ST-segment elevation. Cardiovasc. Prev. Rehabil. 2011;18(1):S113.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Singh M., Reeder G.S., Jacobsen S.J., Weston S., Killian J., Roger V.L. Scores for post-myocardial infarction risk stratification in the community. Circulation. 2002;106(18):2309–2314. DOI: 10.1161/01.CIR.0000036598.12888.DE.</mixed-citation><mixed-citation xml:lang="en">Singh M., Reeder G.S., Jacobsen S.J., Weston S., Killian J., Roger V.L. Scores for post-myocardial infarction risk stratification in the community. Circulation. 2002;106(18):2309–2314. DOI: 10.1161/01.CIR.0000036598.12888.DE.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Pimor A., Auffret V., Didier R., Delaunay R., Filippi E., Hacot J.P. et al. Immediate complete revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease treated by primary percutaneous coronary intervention: Insights from the ORBI registry. Arch. Cardiovasc. Dis. 2018;111(11):656–665. DOI: 10.1016/j.acvd.2017.08.005.</mixed-citation><mixed-citation xml:lang="en">Pimor A., Auffret V., Didier R., Delaunay R., Filippi E., Hacot J.P. et al. Immediate complete revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease treated by primary percutaneous coronary intervention: Insights from the ORBI registry. Arch. Cardiovasc. Dis. 2018;111(11):656–665. DOI: 10.1016/j.acvd.2017.08.005.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Mariani J., Macchia A., De Abreu M., Monte G.G.V., Tajer C. Multivessel versus single vessel angioplasty in nonST elevation acute coronary syndromes: A systematic review and metaanalysis. PLoS One. 2016;11(2):1–21. DOI: 10.1371/journal.pone.0148756.</mixed-citation><mixed-citation xml:lang="en">Mariani J., Macchia A., De Abreu M., Monte G.G.V., Tajer C. Multivessel versus single vessel angioplasty in nonST elevation acute coronary syndromes: A systematic review and metaanalysis. PLoS One. 2016;11(2):1–21. DOI: 10.1371/journal.pone.0148756.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Widimsky P., Holmes D.R. How to treat patients with ST-elevation acute myocardial infarction and multi-vessel disease? Eur. Heart J. 2011;32(4):396–403. DOI: 10.1093/eurheartj/ehq410.</mixed-citation><mixed-citation xml:lang="en">Widimsky P., Holmes D.R. How to treat patients with ST-elevation acute myocardial infarction and multi-vessel disease? Eur. Heart J. 2011;32(4):396–403. DOI: 10.1093/eurheartj/ehq410.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Halkin A., Singh M., Nikolsky E., Grines C.L., Tcheng J.E., Garcia E. et al. Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: The CADILLAC risk score. J. Am. Coll. Cardiol. 2005;45(9):1397–1405. DOI: 10.1016/j.jacc.2005.01.041.</mixed-citation><mixed-citation xml:lang="en">Halkin A., Singh M., Nikolsky E., Grines C.L., Tcheng J.E., Garcia E. et al. Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: The CADILLAC risk score. J. Am. Coll. Cardiol. 2005;45(9):1397–1405. DOI: 10.1016/j.jacc.2005.01.041.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Hoang T.H., Maiskov V. V., Merai I.A., Kobalava Z.D. Development and validation of a model for predicting 18-month mortality in type 2 myocardial infarction. Am. J. Emerg. Med. 2021;48:224–230. DOI: 10.1016/j.ajem.2021.04.060.</mixed-citation><mixed-citation xml:lang="en">Hoang T.H., Maiskov V. V., Merai I.A., Kobalava Z.D. Development and validation of a model for predicting 18-month mortality in type 2 myocardial infarction. Am. J. Emerg. Med. 2021;48:224–230. DOI: 10.1016/j.ajem.2021.04.060.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Krumholz H.M., Chen J., Chen Y.T., Wang Y., Radford M.J. Predicting one-year mortality among elderly survivors of hospitalization for an acute myocardial infarction: Results from the cooperative cardiovascular project. J. Am. Coll. Cardiol. 2001;38(2):453–459. DOI: 10.1016/S0735-1097(01)01395-X.</mixed-citation><mixed-citation xml:lang="en">Krumholz H.M., Chen J., Chen Y.T., Wang Y., Radford M.J. Predicting one-year mortality among elderly survivors of hospitalization for an acute myocardial infarction: Results from the cooperative cardiovascular project. J. Am. Coll. Cardiol. 2001;38(2):453–459. DOI: 10.1016/S0735-1097(01)01395-X.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Erickson S.R., Cole E., Kline-Rogers E., Eagle K.A. The addition of the Charlson comorbidity index to the GRACE risk prediction index improves prediction of outcomes in acute coronary syndrome. Popul. Health Manag. 2014;17(1):54–59. DOI: 10.1089/pop.2012.0117.</mixed-citation><mixed-citation xml:lang="en">Erickson S.R., Cole E., Kline-Rogers E., Eagle K.A. The addition of the Charlson comorbidity index to the GRACE risk prediction index improves prediction of outcomes in acute coronary syndrome. Popul. Health Manag. 2014;17(1):54–59. DOI: 10.1089/pop.2012.0117.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Spoon D.B., Lennon R.J., Psaltis P.J., Prasad A., Holmes D.R. Jr., Lerman A. et al. Prediction of cardiac and noncardiac mortality after percutaneous coronary intervention. Circ. Cardiovasc. Interv. 2015;8(9):1–9. DOI: 10.1161/CIRCINTERVENTIONS.114.002121.</mixed-citation><mixed-citation xml:lang="en">Spoon D.B., Lennon R.J., Psaltis P.J., Prasad A., Holmes D.R. Jr., Lerman A. et al. Prediction of cardiac and noncardiac mortality after percutaneous coronary intervention. Circ. Cardiovasc. Interv. 2015;8(9):1–9. DOI: 10.1161/CIRCINTERVENTIONS.114.002121.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Lemor A., Hernandez G.A., Patel N., Blumer V., Sud K., Cohen M.G. et al. Predictors and etiologies of 30-day readmissions in patients with non-ST-elevation acute coronary syndrome. Catheter Cardiovasc. Interv. 2019;93(3):373–379. DOI: 10.1002/ccd.27838.</mixed-citation><mixed-citation xml:lang="en">Lemor A., Hernandez G.A., Patel N., Blumer V., Sud K., Cohen M.G. et al. Predictors and etiologies of 30-day readmissions in patients with non-ST-elevation acute coronary syndrome. Catheter Cardiovasc. Interv. 2019;93(3):373–379. DOI: 10.1002/ccd.27838.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
